Prospective randomized controlled trial comparing efficacy of 1-L Peg-Asc with prucalopride and 2-L Peg-Asc for the bowel preparation.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Seong Ji | - |
dc.contributor.author | Jeen, Yoon Tae | - |
dc.contributor.author | Kim, Eun Sun | - |
dc.contributor.author | Kim, Woojung | - |
dc.contributor.author | Min, Geeho | - |
dc.contributor.author | Lee, Jae Min | - |
dc.contributor.author | Kim, Seung Han | - |
dc.contributor.author | Yoo, In Kyung | - |
dc.contributor.author | Choi, Hyuk Soon | - |
dc.contributor.author | Keum, Bora | - |
dc.contributor.author | Lee, Hong Sik | - |
dc.contributor.author | Chun, Hoon Jai | - |
dc.contributor.author | Kim, Chang Duck | - |
dc.date.available | 2021-01-15T04:41:07Z | - |
dc.date.issued | 20180201 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.issn | 1527-7755 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/47720 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.title | Prospective randomized controlled trial comparing efficacy of 1-L Peg-Asc with prucalopride and 2-L Peg-Asc for the bowel preparation. | - |
dc.type | Conference | - |
dc.identifier.doi | 10.1200/JCO.2018.36.4_suppl.597 | - |
dc.citation.title | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.citation.startPage | 597 | - |
dc.citation.endPage | 597 | - |
dc.citation.conferenceName | 2018 Gastrointestinal Cancers Symposium | - |
dc.citation.conferencePlace | 미국 | - |
dc.citation.conferencePlace | San Francisco, CA | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.